Showing 6,941 - 6,960 results of 12,750 for search '"therapeutics"', query time: 0.09s Refine Results
  1. 6941

    Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone by Xingming Shi, Mark Hamrick, Carlos M. Isales

    Published 2007-01-01
    “…We propose that inhibition of PPAR-γ2 expression in mesenchymal stem cells by use of some of the hormones/factors mentioned above may be a useful therapeutic strategy to favor bone formation.…”
    Get full text
    Article
  2. 6942

    Du discours au comportement. La validité de la théorie des instances by Ivan Darrault-Harris

    Published 2025-02-01
    “…D’où la difficulté, pour le thérapeute, de saisir la nature de l'instance à l'instant « t », afin de s’y ajuster au mieux en proposant au patient de poursuivre ou de modifier sa quête identitaire : un cas clinique illustrera ce type de situation. …”
    Get full text
    Article
  3. 6943

    Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus by Termpanit Chalermpalanupap, David Weinshenker, Jacki M. Rorabaugh

    Published 2017-01-01
    “…Recent evidence suggests that LC neurons accumulate aberrant tau species for decades before frank LC cell body degeneration occurs in AD, suggesting that a therapeutic window exists. In this review, we combine the literature on how pathogenic tau affects forebrain neurons with the known properties and degeneration patterns of LC neurons to synthesize hypotheses on hyperphosphorylated tau-induced dysfunction of LC neurons and the prion-like spread of pretangle tau from the LC to the forebrain. …”
    Get full text
    Article
  4. 6944

    Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy by Carla Sanjurjo-Soriano, Vasiliki Kalatzis

    Published 2018-01-01
    “…Due to the anatomical accessibility and immunoprivileged status of the eye, ophthalmological research has been at the forefront of innovative and advanced gene- and cell-based therapies, both of which represent great potential as therapeutic treatments for IRD patients. However, due to a genetic and clinical heterogeneity, certain IRDs are not candidates for these approaches. …”
    Get full text
    Article
  5. 6945

    Perilymph Fistula as a Complication of Eustachian Tube Dilation and Tympanoplasty by R. Kim, L. U. Scholtz, R. Jadeed, C. J. Pfeiffer, H. Sudhoff, I. Todt

    Published 2022-01-01
    “…Eustachian tube dilation (ETD) is an established, minimally invasive therapeutic approach for chronic eustachian tube dysfunction. …”
    Get full text
    Article
  6. 6946

    Prostanoid Receptors in the Human Vascular Wall by Xavier Norel

    Published 2007-01-01
    “…Consequently, the EP receptor subtypes or isoforms would provide a novel and specific cardiovascular therapeutic approach in the near future.…”
    Get full text
    Article
  7. 6947

    Baricitinib Successfully Treated a Teenager with Refractory Livedoid Vasculopathy: A Case Report and Literature Review by Liu C, Jin YY, Han X, Huang H, Bao S, Xu X, Wang L, Jin Y

    Published 2025-02-01
    “…However, the symptoms improved significantly 2 weeks after treatment with baricitinib, and remission was maintained during its gradual reduction.Conclusion: Successful treatment of this refractory patient with baricitinib provides another evidence for the potential therapeutic effect of JAK1/JAK2 inhibitors in LV, and also offers a reference for the dosage tapering regime of baricitinib in LV.Keywords: livedoid vasculopathy, refractory, baricitinib…”
    Get full text
    Article
  8. 6948

    The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease by Maja Stojancevic, Karmen Stankov, Momir Mikov

    Published 2012-01-01
    “…These data suggest that FXR agonists are potential candidates for exploration as a novel therapeutic strategy for IBD in humans.…”
    Get full text
    Article
  9. 6949

    Plasticity and Awareness of Bodily Distortion by Mariella Pazzaglia, Marta Zantedeschi

    Published 2016-01-01
    “…For each of these views, we briefly discuss abnormalities and therapeutic strategies for correcting the bodily distortions in various clinical disorders.…”
    Get full text
    Article
  10. 6950

    Fibromyalgia: Presentation and Management with a Focus on Pharmacological Treatment by Janice E Sumpton, Dwight E Moulin

    Published 2008-01-01
    “…Response and tolerance of different therapeutic interventions vary from patient to patient. …”
    Get full text
    Article
  11. 6951

    The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination by Graham Skelhorne-Gross, Christopher J. B. Nicol

    Published 2012-01-01
    “…In spite of this, several groups reported exciting results with therapeutic regimens that combine PPARγ ligands with other compounds: chemotherapeutic agents, retinoid x receptor (RXR)α agonists, statins, or cell-to-cell signaling molecules in preclinical cancer models and human trials. …”
    Get full text
    Article
  12. 6952

    Case Report: Homozygous C677T MTHFR Gene Mutation in Male with Hypogonadism by Rami Salameh, Mumtaheena Miah, Catherine Anastasopoulou

    Published 2020-01-01
    “…He persistently complained of fatigue despite increasing the dose of testosterone over two years and having therapeutic testosterone levels. He was found to have homozygous C677T methylenetetrahydrofolate reductase (MTHFR) gene mutation. …”
    Get full text
    Article
  13. 6953

    Effectiveness of scapular retraction exercises and kinesio taping in individuals with protracted shoulders: A randomized control trial by Divya Gohil, Mokshi Koul, Gaurang Baxi

    Published 2024-07-01
    “…Kinesiology Taping is a therapeutic tool to unload the fascia and assist in the relief of chronic pain. …”
    Get full text
    Article
  14. 6954

    Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines? by Baba Sulemana Mohammed, Matthew Aidoo

    Published 2020-01-01
    “…The diverse influence of liver function on drug disposition can lead health-care practitioners to inappropriate drug selection, inappropriate drug dosing, or some level of therapeutic negativism. The aim of this study was to assess how drug prescribing in patients with liver cirrhosis at the Tamale Teaching Hospital comply with recommendations of pharmacotherapy and safety guidelines. …”
    Get full text
    Article
  15. 6955

    Motion – The Available Treatments for Hepatitis C Are Cost Effective: Arguments against the Motion by W Ray Kim

    Published 2002-01-01
    “…Although a substantial improvement has been made in the treatment for HCV, the overall impact of antiviral therapy in altering the natural course of HCV infection remains uncertain. Therapeutic trials involve narrow selection criteria that would exclude the majority of hepatitis C patients in the community, and are conducted in ideal settings that may not be generalizable to the average practice setting. …”
    Get full text
    Article
  16. 6956

    Metabolic Characteristics of Oxcarbazepine (®Trileptal) and their Beneficial Implications for Enzyme Induction and Drug Interactions by Johann W. Faigle, Guenter P. Menge

    Published 1990-01-01
    “…Pharmacokinetic behaviour is thus often altered, especially in combined medication, so that the dosage has to be re-adjusted if an optimum therapeutic outcome is to be ensured. Oxcarbazepine (OXC) is a keto analogue of CBZ. …”
    Get full text
    Article
  17. 6957

    Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns by Maria Portelli, Byron Baron

    Published 2018-01-01
    “…Other than the delivery of the foetus and the removal of the placenta, to date there are no therapeutic approaches to treat or prevent PE. It is thus only possible to reduce PE-related mortality through early detection, careful monitoring, and treatment of the symptoms. …”
    Get full text
    Article
  18. 6958

    Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors by Gulfiya Kadyrzhanova, Miho Tamai, Shukla Sarkar, Rajkumar Singh Kalra, Hiroki Ishikawa

    Published 2025-01-01
    “…These findings suggest that aging-induced reduction of Epas1 expression impairs anti-tumor activity of CD8 T cells in ACT against solid tumors, which can be therapeutically improved by expression of exogenous Epas1.…”
    Get full text
    Article
  19. 6959

    Urothelial Cancer Stem Cells by Irena Dimov, Milan Visnjic, Vladisav Stefanovic

    Published 2010-01-01
    “…This review examines the present knowledge on CSCs in UCCs regarding the similarities between CSCs and the adult urothelial stem cells, potential origin of urothelial CSCs, main regulatory pathways, surface markers expression, and the current state of CSC-targeting therapeutic strategies.…”
    Get full text
    Article
  20. 6960

    The Role of Health Anxiety among Patients with Chronic Pain in Determining Response to Therapy by Heather D Hadjistavropoulos, Gordon JG Asmundson, Diane L LaChapelle, Allisson Quine

    Published 2002-01-01
    “…The present investigation extends the current understanding of HA and explores whether it affects how patients respond to a common therapeutic intervention, namely instructions to reduce pain behaviour. …”
    Get full text
    Article